Skip to main content
Premium Trial:

Request an Annual Quote

Viollier to Offer Epigenomics' Colorectal Cancer Test

NEW YORK (GenomeWeb News) – Swiss diagnostics lab Viollier has obtained rights to offer Epigenomics' molecular test for colorectal cancer detection as a service to patients in Europe beginning July 1.

Berlin-based Epigenomics said that the test is based on its mSEPT9 biomarker and is the first ever blood-based test for colorectal cancer to be offered in Europe. It said that it expects other diagnostic labs in Europe to offer mSEPT9 testing "in due course."

In addition, Epigenomics said that mSEPT9 testing in the US would initially be offered by Quest Diagnostics.

"Blood sampling is easy and convenient for both the patient and the doctor," Edouard Viollier, chairman of Viollier's board of directors, said in a statement. "We believe that this could be the future of non-invasive colorectal cancer screening and key to increasing compliance to screening programs."

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.